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Abstract
Background—Rats with several hundred-fold elevation of plasma prorenin levels due to liver-
specific expression of a rat prorenin transgene have cardiac and aortic hypertrophy, renal lesions
and myocardial fibrosis. The effect of increased dietary NaCl on the phenotype of prorenin
transgenic rats has not been examined.
Methods and results—We compared the effects of 0.3% and 2% dietary NaCl in wildtype and
transgenic rats from 3-12 months of age. In comparison with wildtype rats, transgenic rats
receiving 0.3% dietary NaCl had ~1000-fold elevation of prorenin, 1.5- to 2.5-fold elevation of
renin concentration and activity, wildtype levels of angiotensin II, and were hypertensive with
cardiac and aortic hypertrophy, and increased renal glomerular and tubulo-interstitial injury score.
In wildtype rats, 2% dietary NaCl reduced angiotensin levels, produced a delayed increase in
blood pressure, and caused cardiac hypertrophy and tubulo-interstitial injury. By contrast, 2%
NaCl did not reduce angiotensin levels in transgenic rats, potentiated their hypertension, cardiac
and aortic hypertrophy, and increased myocardial interstitial and perivascular fibrosis, without
effect on glomerular or tubulo-interstitial injury score.
Conclusion—Increased dietary NaCl had a greater impact on the phenotype of transgenic than
wildtype rats that may have been due in part to their hypertension and their failure to suppress
angiotensin levels, consequent to their elevated prorenin levels.
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Introduction
Prorenin, the biosynthetic precursor of renin, contains a prosegment that masks the active
site, thereby preventing access by the renin substrate, angiotensinogen [1,2]. Plasma
prorenin concentrations are 10- to 20-fold higher than renin concentrations in humans [3,4],
and there is controversy whether plasma prorenin has biological activity in vivo [1,2]. Partial
conversion to renin, and a low degree of intrinsic activity due to transitory unfolding of the
prosegment, may contribute to angiotensin formation by prorenin. In addition, prorenin
binding to the (pro)renin receptor may initiate signal transduction by mechanisms
independent of angiotensin peptide formation, and the (pro)renin receptor may activate
prorenin by promoting unfolding of the prosegment [1,2,5].
Transgenic animal models with elevated prorenin levels are valuable for study of the role of
prorenin in vivo. We previously reported the (hAT-rpR) rat with liver-specific expression of
a rat prorenin transgene under the control of a human α1-antitrypsin promoter. Plasma
prorenin levels of male (hAT-rpR) rats were ~600-fold higher than in wildtype (WT) rats,
and male (hAT-rpR) rats exhibited cardiac hypertrophy and severe renal lesions,
hypertrophic cardiomyocytes, interstitial and perivascular fibrosis in the heart, increased
aortic wall thickness, and suppressed kidney renin levels, despite WT levels of plasma renin
activity (PRA) and systolic blood pressure (SBP) [6]. However, in contrast to our initial
report of male (hAT-rpR) rats housed in Edinburgh [6], we subsequently found that male
(hAT-rpR) rats housed in Paris were hypertensive by 3 months of age, and developed
modest renal lesions and cardiac fibrosis only after 6 months of age [7]. Plasma and kidney
angiotensin (Ang) II levels of male (hAT-rpR) rats were similar to the levels in WT
littermates, and nephrectomy experiments showed liver-derived prorenin was the major
contributor to plasma Ang II levels in (hAT-rpR) rats that likely contributed to their
hypertension, cardiac hypertrophy and suppressed kidney renin levels.
We were unable to explain the differences in phenotype of (hAT-rpR) rats in our two
studies. Given the hypertension and more benign phenotype of (hAT-rpR) rats housed in
Paris, we were interested to explore factors that may modify their phenotype. Increased
dietary NaCl is well recognized to cause hypertension and cardiovascular disease and to
amplify the hypertensive and pathogenic effects of Ang II [8-10], and the mouse prorenin
transgenic (mRen-2)27 rat is particularly susceptible to dietary NaCl [11]. We therefore
studied the effect of 2% NaCl, in comparison with 0.3% NaCl, from 3 to 12 months of age
on blood pressure, the renin angiotensin system, and organ pathology in male WT and
(hAT-rpR) rats. We hypothesized that (hAT-rpR) rats may not suppress Ang II levels and
may therefore show an exaggerated increase in blood pressure and organ pathology in
response to increased dietary NaCl.
Materials and Methods
The generation of (hAT-rpR) rats by the Centre for Genome Research, Edinburgh, has been
described [6]. This transgenic rat line was created by inserting a rat prorenin cDNA fused to
a human α1-antitrypsin promoter into the genome of the Fischer F344 rat. In December
1996, 9 male and 12 female heterozygous (hAT-rpR) rats, strain 85-26, and 8 WT male
Fischer F344 rats were received at INSERM U367, Paris, France. The colony was
maintained by mating heterozygous male and female (hAT-rpR) rats. Because expression of
the rat prorenin transgene in (hAT-rpR) rats showed sexual dimorphism and because only
male rats showed renal, cardiac and aortic abnormalities [6], our study was confined to
heterozygous male (hAT-rpR) rats and their WT male littermates, and was carried out in
accordance with the European Convention for the Protection of Vertebrate Animals used for
Experimental and Other Scientific Purposes. All rats were genotyped by PCR of DNA
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obtained from tail biopsies as previously described [7]. The rat experiments were completed
in 1999.
Experimental procedures
Rats were housed in groups of 4-5 animals, lights on from 08.00-19.00, and were fed a
normal rat diet containing 0.3% NaCl, and tap water ad libitum. At 3 months of age, WT and
(hAT-rpR) rats were randomized to either continue the normal rat diet or to commence an
equivalent diet with 2% NaCl. Both diets contained 0.9% potassium. We previously showed
these diets, prepared by UAR, Epinay-sur-Orge, France, ensure similar rat growth rates [12].
Food intake was not measured. SBP and body weight were measured every 3 months; SBP
was measured in conscious rats using tail-cuff plethysmography.
Collection of blood and tissues
At 3 months of age (just before commencement of 2% NaCl diet) and at 6, 9, and 12 months
of age, blood (1 mL) for measurement of PRA, plasma renin concentration (PRC), prorenin
and angiotensinogen was taken from the jugular vein under light anaesthesia with ketamine-
xylazine (15 and 5 mg/kg body weight, respectively, by intra-peritoneal injection) [12] into a
syringe with ~0.05 vol 2.5 mmol/L Ω-phenanthroline, 0.1 mol/L EDTA to inhibit
angiotensin converting enzyme and angiotensinase activity, and centrifuged at 4,000 g for
10 min. Plasma was stored at −80°C for subsequent assay. At 12 months of age, after
collection of blood from the jugular vein, blood (≤10 mL) for measurement of angiotensin
peptides was collected from the aorta into a syringe containing 0.5 mL 0.1 mmol/L rat renin
inhibitor kindly provided by Dr Hiwada [13], 0.01 mmol/L MK 422 and 1 mmol/L EDTA.
The organs were sampled immediately after blood collection. A portion of liver was frozen
in liquid nitrogen for RNA extraction. The left and right ventricles were dissected, blotted
and weighed. The kidneys were cut longitudinally into 2 equal portions and one portion was
frozen in liquid nitrogen for renin measurement. The other portion of kidney was placed in
alcoholic Bouin's fixative and the heart and the abdominal aorta were placed in 4%
paraformaldehyde for histological and morphometric analyses.
Measurement of plasma prorenin, renin, angiotensin peptides and angiotensinogen, and
renal renin
Plasma prorenin, PRA, PRC, angiotensin peptides and angiotensinogen, and renal renin
were measured as previously described [7].
Northern blot analysis
Total RNA was extracted from liver using Tri-Reagent solution (Molecular Research
Centre), electrophoresed on 1% agarose gels, transferred to supercharged nylon membrane
(Schleicher & Schuell) and fixed by UV cross-linking. The Northern blots were probed for
renin mRNA using 32P-labeled mouse submaxillary gland renin cDNA prepared using a
random primer labeling kit (Prime-It II, Stratagene). Renin hybridization signal was
normalized to that of GAPDH.
Analysis of renal histology
Kidneys from male (hAT-rpR) and WT rats, fixed in alcoholic Bouin's solution, were
embedded in paraffin, and 2 sagittal sections (4 μm) were stained with Masson's trichrome
and examined under light microscopy. Two investigators blinded as to the experimental
groups graded the severity of the morphological changes semiquantitatively as described
previously [7,14,15]. For assessing glomerulosclerosis, 30 superficial and 30 juxtamedullary
glomeruli in each kidney were observed at X400 magnification and a glomerular damage
index was calculated for the 60 glomeruli [7]. For tubulo-interstitial lesions (interstitial
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inflammation and fibrosis, tubular atrophy and casts) every third field of each kidney (total
of 10 fields/kidney) was assessed at X100 magnification and the score corresponding to
tubulo-interstitial lesions was obtained for each kidney [7]. The vascular lesion score was
obtained as described previously [7].
Analysis of cardiac fibrosis and aortic medial hypertrophy
Heart and abdominal aorta from male (hAT-rpR) and WT rats, fixed in 4%
paraformaldehyde, were embedded in paraffin. Two coronal ventricular sections (4 μm)
were taken at the equator of the heart and 3 sequential sections (4 μm) were taken from the
mid portion of the abdominal aorta. The cardiac sections were stained for collagen with
picrosirius red and the aortic sections were stained for elastin with orcein. Cardiac and aortic
measurements were determined by quantitative morphometry of digitized images using
Aperio instrumentation (Aperio Technologies, Inc., CA). Left ventricular myocardial
interstitial collagen density was calculated using the positive pixel count algorithm as the
area of collagen staining expressed as a percentage of the total myocardial tissue area, after
excluding perivascular fibrosis. Perivascular fibrosis and wall/lumen ratio of
intramyocardial vessels were measured by planimetry of vessels with a maximum/minimum
cross-sectional diameter ratio <1.5 and average maximum diameter ~60 μm (range 20-130
μm), and the median value of an average of 4-6 vessels was determined for each rat.
Perivascular fibrosis was calculated as the ratio of the area of perivascular fibrosis to the
total vessel area (area of vessel wall plus lumen) [16]. The wall/lumen ratio was calculated
as the ratio of the area of the vessel wall to the lumen area.
Abdominal aortic cross-sectional area, wall area, and outer and inner aortic wall
circumference were estimated by planimetry. Two sections were analyzed for each rat. The
aortic wall thickness was calculated as the ratio of the wall area to the average mid-
circumference of the aortic wall. Investigators responsible for morphometric analyses were
blinded as to experimental group.
Statistical analysis
Data are expressed as means±SEM. Calculations were done with Statview 5.0.1 statistical
software (SAS Institute Inc.), and a value of P<0.05 was considered significant. Body
weight, SBP, prorenin, PRC and PRA were analyzed by repeated measures analysis of
variance (ANOVA). Other data were analyzed by 2-way ANOVA. Data were
logarithmically transformed when necessary to normalize variances. The Fisher's Protected
Least Significant Difference test was used for multiple comparisons.
Results
Body weight, SBP, and left ventricular and kidney weights
The effects of 2% dietary NaCl on body weight and systolic blood pressure are shown in
Figure 1. There was no difference in body weight between WT and (hAT-rpR) rats, and 2%
dietary NaCl did not influence body weight of either genotype, when analyzed by 2-way
repeated measures ANOVA for 3-12 months of age. However, separate analysis of 12 month
body weight data showed the body weight of (hAT-rpR) rats receiving 2% dietary NaCl was
less than that of WT rats receiving 2% dietary NaCl (Figure 1). Blood pressure was higher in
(hAT-rpR) than in WT rats, and 2% dietary NaCl increased blood pressure of both
genotypes. The increase in blood pressure with 2% dietary NaCl was more rapid for (hAT-
rpR) than for WT rats, but by 12 months of age, after 9 months of 2% dietary NaCl, the
absolute blood pressure increase was similar for the 2 genotypes. At 12 months of age, SBP
was 148±5 mmHg (mean ± SEM, n = 7) and 170±4 mmHg (n = 8) for WT and (hAT-rpR)
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rats, respectively, receiving 0.3% NaCl, and 2% dietary NaCl increased SBP of WT rats to
164±7 mmHg (n = 8) and SBP of (hAT-rpR) rats to 187±7 mmHg (n = 8).
Left ventricular weight and left ventricular weight/body weight ratio were higher in (hAT-
rpR) than WT rats, and 2% dietary NaCl increased left ventricular weight and left
ventricular weight/body weight ratio for both genotypes (Table 1). There were no
differences between WT and (hAT-rpR) rats for kidney weight or kidney weight/body
weight ratio; 2-way ANOVA showed a significant increase in kidney weight/body weight
ratio with 2% dietary NaCl, but this effect of 2% dietary NaCl was not significant when
tested for each genotype separately (Table 1).
Plasma prorenin, renin, angiotensin peptides and angiotensinogen, and renal renin
Plasma prorenin, PRC, and PRA were measured at 3, 6, 9, and 12 months of age (Figure 2).
At 12 months of age, prorenin levels were 68979±22788 (mean ± SEM, n = 8) ng Ang I/mL
per h and 16938±3981 (n = 8) ng Ang I/mL per h for 0.3% and 2% dietary NaCl,
respectively in (hAT-rpR) rats and 69±15 (n = 7) ng Ang I/mL per h and 30±10 (n = 7) ng
Ang I/mL per h for WT rats. Thus, prorenin levels of (hAT-rpR) rats were ~1000-fold
higher than in WT rats and, in comparison with 0.3% dietary NaCl, 2% dietary NaCl
reduced prorenin by ~75% in (hAT-rpR) rats and by ~56% in WT rats. PRA and PRC of
(hAT-rpR) rats were 1.5- to 2.5-fold higher than in WT rats and, in comparison with 0.3%
dietary NaCl, 2% dietary NaCl reduced PRA by ~39% in (hAT-rpR) rats and by ~49% in
WT rats, but did not reduce PRC in either genotype at 12 months of age.
Plasma Ang I and Ang II, angiotensinogen and kidney renin were measured at 12 months of
age (Table 1). Ang II levels of (hAT-rpR) rats were similar to WT levels but Ang I levels
were lower than WT levels on 0.3% dietary NaCl. Increased dietary NaCl reduced Ang I and
Ang II levels in WT, but not in (hAT-rpR), rats. Plasma angiotensinogen levels were lower
in (hAT-rpR) than in WT rats, and were not influenced by 2% dietary NaCl. Kidney renin
levels were suppressed in (hAT-rpR) rats; whereas 2% dietary NaCl reduced kidney renin
levels in WT rats, it had no effect on the already suppressed kidney renin levels in (hAT-
rpR) rats.
Liver renin mRNA levels
In agreement with the reduction in plasma prorenin levels by 2% dietary NaCl, Northern
blot analysis at 12 months of age showed a 37% reduction in hepatic renin mRNA levels in
(hAT-rpR) rats; renin/GAPDH ratio: 11.4±0.7 (mean ± SEM, n=4) for 0.3% dietary NaCl,
7.2±1.2 (n=5) for 2% dietary NaCl, P = 0.02. Renin mRNA was not detectable in livers of
WT rats.
Renal histology
At 12 months of age the proportion of normal glomeruli for WT rats was 98% (range
95-100%) for 0.3% dietary NaCl and 98% (93-100%) for 2% dietary NaCl, and for (hAT-
rpR) rats was 90% (73-100%) for 0.3% dietary NaCl and 89% (73-100%) for 2% dietary
NaCl. Glomerular injury score was higher in (hAT-rpR) than in WT rats but 2% dietary
NaCl did not affect glomerular injury score in either genotype (Figures 3 and 4).
The proportion of normal tubulo-interstitium for WT rats was 91% (range 70-100%) for
0.3% dietary NaCl and 60% (30-90%) for 2% dietary NaCl, and for (hAT-rpR) rats was
41% (10-90%) for 0.3% dietary NaCl and 28% (0-70%) for 2% dietary NaCl. Tubulo-
interstitial injury score was higher in (hAT-rpR) than in WT rats and 2% dietary NaCl
increased tubulo-interstitial injury score in WT, but not in (hAT-rpR), rats. None of the WT
rats receiving 0.3% or 2% dietary NaCl and none of the (hAT-rpR) rats receiving 0.3%
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dietary NaCl had vascular lesions; only 2 of the 8 (hAT-rpR) rats receiving 2% dietary NaCl
had vascular lesions. Thus, neither genotype nor dietary NaCl affected kidney vascular
injury score.
Aorta
Abdominal aortic cross-sectional area, wall area and thickness were higher in (hAT-rpR)
than in WT rats (Table 1). While without effect on aortic wall area and thickness in WT rats,
2% dietary NaCl increased both parameters in (hAT-rpR) rats. However, dietary NaCl did
not influence aortic cross-sectional area of either genotype.
Cardiac histology
Myocardial interstitial and perivascular fibrosis and myocardial vessel wall/lumen ratio were
similar for (hAT-rpR) and WT rats receiving 0.3% dietary NaCl (Figures 5 and 6). Increased
dietary NaCl increased myocardial interstitial and perivascular fibrosis in (hAT-rpR), but
not in WT, rats; however, dietary NaCl did not influence myocardial vessel wall/lumen ratio
of either genotype.
Discussion
We found that an increase in dietary NaCl from 0.3% to 2% produced a greater impact on
the phenotype of (hAT-rpR) than of WT rats. Increased dietary NaCl potentiated the
hypertension, cardiac and aortic hypertrophy, and increased myocardial interstitial and
perivascular fibrosis, without effect on myocardial vessel wall/lumen ratio, or renal
glomerular, tubulo-interstitial, or vascular injury score in (hAT-rpR) rats. By contrast, 2%
dietary NaCl produced only a delayed increase in blood pressure of WT rats, in association
with an increase in left ventricular weight and tubulo-interstitial injury, but no other cardiac,
renal, or vascular consequences. The greater susceptibility of (hAT-rpR) rats to increased
dietary NaCl may have been due in part to their hypertension and their failure to suppress
angiotensin levels in response to increased dietary NaCl. As we have previously reported for
(hAT-rpR) rats housed in Paris, ~1000-fold increase in prorenin levels had a modest impact
on cardiac, renal and vascular morphology, in association with increased blood pressure [7].
Increased prorenin levels did not affect myocardial interstitial or perivascular fibrosis in the
present study, although 2% dietary NaCl increased myocardial interstitial and perivascular
fibrosis in (hAT-rpR), but not in WT, rats.
Increased dietary NaCl produced the expected suppression of plasma prorenin, PRC, PRA
and angiotensin peptide levels, and kidney renin levels in WT rats. The suppression of
plasma prorenin and PRA in (hAT-rpR) rats was, however, unexpected. The reduction in
prorenin mRNA levels in liver of (hAT-rpR) rats suggested an effect of 2% dietary NaCl on
transcription of the transgene, which was under the control of the human α1-antitrypsin
promoter. However, rat hepatic α1-antitrypsin mRNA levels are unresponsive to 8% dietary
NaCl [17], and it is therefore unknown why the human α1-antitrypsin promoter of the rat
prorenin transgene may have responded to increased dietary NaCl. The markedly lower
kidney renin levels in (hAT-rpR) than WT rats on 0.3% NaCl diet was confirmation of our
earlier studies [6,7], and the failure of 2% dietary NaCl diet to further reduce kidney renin
levels in (hAT-rpR) rats was consistent with these levels representing trapped plasma
prorenin in the tissue, that was subsequently activated during tissue processing before renin
assay.
Although (hAT-rpR) rats had higher PRC and PRA levels than WT rats on 0.3% dietary
NaCl, their angiotensin peptide levels were not elevated. As we have previously discussed
[7], the higher PRC and PRA levels in (hAT-rpR) rats were probably due to in part to
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inadvertent in vitro activation of the ~1000-fold elevated prorenin levels during collection
and processing of blood and performance of the PRC and PRA assays. Thus, the fall in PRA
in (hAT-rpR) rats given 2% dietary NaCl was likely a consequence of the fall in prorenin
levels. However, given that our previous studies of the effects of nephrectomy indicated a
predominant contribution of liver-derived prorenin to angiotensin peptide formation in
(hAT-rpR) rats, we are unable to explain why the lower prorenin levels in (hAT-rpR) rats
given 2% dietary NaCl were not accompanied by lower Ang I and Ang II levels, although
these data raise the possibility that dietary NaCl may modulate the contribution of prorenin
to angiotensin peptide formation.
Most previous studies of the effects of increased dietary NaCl in rats used 8% dietary NaCl,
which increased blood pressure and induced cardiac and renal hypertrophy and myocardial
and renal fibrosis in both normotensive and spontaneously hypertensive rats [8,9]. Our
comparison of 0.3% and 2% dietary NaCl was more physiological in that the 7-fold
difference in NaCl intake was less than the differences in NaCl intake used in some clinical
studies [18,19]. Simon and Illyes found no effect of 2% dietary NaCl on blood pressure of
Sprague Dawley rats over 12 weeks [10], in agreement with the present finding that greater
than 3 months duration of 2% dietary NaCl was required to increase blood pressure of WT
rats. Increased dietary NaCl is well recognized to amplify the hypertensive and pathogenic
effects of Ang II [8-10]. Ang II administration at a dose that was subpressor in rats given
0.7% dietary NaCl was pressor and produced vascular hypertrophy in rats given 2% dietary
NaCl [10]. Thus, the lack of suppression of Ang II levels by 2% dietary NaCl in (hAT-rpR)
rats would be predicted to exacerbate the effects of increased dietary NaCl in these rats. The
impact of 2% dietary NaCl on the phenotype of (hAT-rpR) rats was less than that reported
for mouse prorenin transgenic (mRen-2)27 rats. In comparison with 0.45% dietary NaCl,
male heterozygous (mRen-2)27 rats fed 2% NaCl from the age of 1 to 6 months developed a
rapid increase in blood pressure with transition to malignant phase hypertension, together
with increased cardiac hypertrophy, proteinuria, and glomerulosclerosis [11]. The greater
effect of 2% dietary NaCl in (mRen-2)27 rats may have been due to their greater elevation
of plasma Ang II levels [20,21].
In summary, we found an increase in dietary NaCl from 0.3% to 2% had a much greater
impact on the phenotype of (hAT-rpR) than WT rats. Increased dietary NaCl potentiated the
hypertension, cardiac and aortic hypertrophy, and myocardial interstitial and perivascular
fibrosis of (hAT-rpR) rats, without modification of myocardial vessel wall/lumen ratio or
renal histology. The increased susceptibility of (hAT-rpR) rats to increased dietary NaCl
may have been due in part to their hypertension and their failure to suppress angiotensin
levels, consequent to their elevated prorenin levels, and to an effect of dietary NaCl on
angiotensin peptide formation by prorenin. It is of note, however, that plasma prorenin
levels of (hAT-rpR) rats were ~1000-fold higher than physiological levels and further
studies are required to define the contribution of prorenin to organ pathology in conditions
with lesser degrees of elevation of prorenin levels, such as diabetes and pregnancy.
Condensed abstract
Rats with several hundred-fold elevation of plasma prorenin levels due to liver-specific
expression of a rat prorenin transgene have cardiac and aortic hypertrophy, renal lesions
and myocardial fibrosis. We compared the effects of 0.3% and 2% dietary NaCl in
wildtype and transgenic rats from 3-12 months of age. In contrast to wildtype rats, 2%
NaCl did not reduce angiotensin levels in transgenic rats, potentiated their hypertension,
cardiac and aortic hypertrophy, and increased myocardial interstitial and perivascular
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fibrosis. We conclude that increased dietary NaCl had a greater impact on the phenotype
of transgenic than wildtype rats.
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Figure 1.
Effect of 0.3% (circles) and 2% (squares) dietary NaCl on body weight (BW) and systolic
blood pressure (SBP) in male wildtype (WT, open symbols) and (hAT-rpR) rats (closed
symbols). Data shown as means ± SEM, n=7-8. For BW, 2-way repeated measures ANOVA
for 3-12 months of age showed no effect of genotype, dietary NaCl, or interaction between
genotype and dietary NaCl. However, when BW at 12 months was analysed separately,
there was a significant effect of genotype (P=0.03) but not dietary NaCl, and (hAT-rpR) rats
receiving 2% dietary NaCl had lower BW than WT rats receiving 2% dietary NaCl
(P=0.006). For SBP, 2-way ANOVA for 3-12 months of age showed higher SBP in (hAT-
rpR) than WT rats (P<0.0001), and in comparison with 0.3% dietary NaCl, 2% NaCl
increased SBP in both WT (P=0.02) and (hAT-rpR) rats (P=0.004). When SBP at 12 months
was analysed separately, (hAT-rpR) rats receiving 2% dietary NaCl had higher SBP than
WT rats receiving either 0.3% (P=0.0001) or 2% dietary NaCl (P=0.01), and WT rats
receiving 2% dietary NaCl had higher SBP than WT rats receiving 0.3% NaCl (P=0.02).
*P<0.05, †P<0.01 for comparison of indicated groups at 12 months of age.
Campbell et al. Page 10
J Hypertens. Author manuscript; available in PMC 2011 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2.
Effect of 0.3% (circles) and 2% (squares) dietary NaCl on plasma prorenin, renin
concentration (PRC), and renin activity (PRA) in male wildtype (WT, open symbols) and
(hAT-rpR) rats (closed symbols). Data shown as means ± SEM, n=7-8; where error bars are
not shown they are contained with the symbol. For prorenin, 2-way ANOVA for 6-12
months of age showed significant effects of genotype (P<0.0001) and dietary NaCl
(P=0.0003), without interaction between genotype and dietary NaCl, and 2% NaCl reduced
prorenin in both WT (P=0.01) and (hAT-rpR) rats (P=0.0002). When prorenin levels at 12
months were analysed separately, (hAT-rpR) rats had higher prorenin than WT rats for
either diet (P<0.0001), and 2% dietary NaCl reduced prorenin levels for both (hAT-rpR)
(P=0.001) and WT rats (P=0.04). For PRC, 2-way ANOVA for 6-12 months of age showed
significant effects of genotype (P<0.0001) and dietary NaCl (P=0.003), without interaction
between genotype and dietary NaCl, and 2% NaCl reduced PRC in WT (P=0.005) but not in
(hAT-rpR) rats (P=0.06). When PRC at 12 months was analysed separately, (hAT-rpR) rats
receiving either 0.3% (P=0.0002) or 2% dietary NaCl (P=0.001) had higher PRC than WT
rats receiving 2% NaCl, and (hAT-rpR) rats receiving 0.3% NaCl had higher PRC than WT
rats receiving 0.3% NaCl (P=0.03). However, the effect of 2% NaCl on PRC was not
statistically significant for either (hAT-rpR) or WT rats at 12 months of age. For PRA, 2-
way ANOVA for 6-12 months of age showed significant effects of genotype (P<0.0001) and
dietary NaCl (P<0.0001), without interaction between genotype and dietary NaCl, and 2%
NaCl reduced prorenin in both WT (P<0.0001) and (hAT-rpR) rats (P=0.0003). When PRA
at 12 months was analysed separately, (hAT-rpR) rats receiving 0.3% dietary NaCl had
higher PRA than WT rats receiving either 0.3% (P=0.046) or 2% dietary NaCl (P=0.0002),
whereas PRA of (hAT-rpR) rats receiving 2% NaCl was not different from that of WT rats
receiving either diet. Increased dietary NaCl reduced PRA in both (hAT-rpR) (P=0.01) and
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WT rats (P=0.047) at 12 months of age. *P<0.05, †P<0.01 for comparison of indicated
groups at 12 months of age.
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Figure 3.
Effect of 0.3% NaCl diet (open columns) and 2% NaCl diet (closed columns) on renal
glomerular, tubulo-interstitial, and vascular injury scores in male wildtype (WT) and (hAT-
rpR) rats at 12 months of age. Data shown as means ± SEM, n = 7-8. For glomerular injury
score, 2-way ANOVA showed a significant effect of genotype (P=0.002), but not of dietary
NaCl. For tubulo-interstitial injury score, 2-way ANOVA showed a significant effect of both
genotype (P=0.0002) and dietary NaCl (P=0.02); the effect of dietary NaCl was significant
for WT rats (P=0.0004), but not for (hAT-rpR) rats, when analyzed separately. The vascular
injury score was zero for WT rats on either diet and for (hAT-rpR) rats on a 0.3% NaCl diet,
and 2-way ANOVA showed no effect of either genotype or dietary NaCl.
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Figure 4.
Representative kidney sections of wildtype (WT) and transgenic (hAT-rpR) rats
administered either 0.3% or 2% dietary NaCl from 3 to 12 months of age. At 12 months of
age, (hAT-rpR) rats receiving on 0.3% dietary NaCl showed glomerulosclerosis, tubulo-
interstitial inflammation and fibrosis, tubular atrophy and casts, in comparison with WT rats.
In comparison with 0.3% dietary NaCl, 2% dietary NaCl had no affect on glomerular or
tubulo-interstitial injury score of (hAT-rpR) rats, whereas WT rats showed increased tubulo-
interstitial, but not glomerular, injury score in response to 2% dietary NaCl. Masson's
trichrome stain; bar = 50μm.
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Figure 5.
Effect of 0.3% NaCl diet (open columns) and 2% NaCl diet (closed columns) on myocardial
interstitial and perivascular fibrosis, and myocardial vessel wall/lumen ratio in male
wildtype (WT ) and (hAT-rpR) rats at 12 months of age. Data shown as means ± SEM, n =
7-8. For interstitial fibrosis, 2-way ANOVA showed a significant effect of dietary NaCl
(P=0.003), but not of genotype; the effect of dietary NaCl was significant for (hAT-rpR) rats
(P=0.008), but not for WT rats, when analyzed separately. For perivascular fibrosis, 2-way
ANOVA showed a significant effect of dietary NaCl (P=0.03), but not of genotype; the
effect of dietary NaCl was significant for (hAT-rpR) rats (P=0.03), but not for WT rats,
when analyzed separately. For vascular wall/lumen ratio, 2-way ANOVA showed no
significant effect of either genotype or dietary NaCl.
Campbell et al. Page 15
J Hypertens. Author manuscript; available in PMC 2011 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 6.
Representative heart sections of wild type (WT) and transgenic (hAT-rpR) rats administered
either 0.3% or 2% dietary NaCl from 3 to 12 months of age. At 12 months of age, there was
no difference in interstitial or perivascular fibrosis, or myocardial vessel wall/lumen ratio
between WT and (hAT-rpR) rats administered 0.3% dietary NaCl. In comparison with 0.3%
dietary NaCl, 2% dietary NaCl did not modify myocardial interstitial or perivascular fibrosis
in WT rats. However, 2% dietary NaCl increased myocardial interstitial and perivascular
fibrosis in (hAT-rpR) rats. Dietary NaCl did not influence myocardial vessel wall/lumen
ratio in either WT or (hAT-rpR) rats. Sirius red staining collagen; bar = 200μm.
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